Genomic profiling toward precision medicine in non-small cell lung cancer: getting beyond EGFR

Lung cancer remains the leading cause of cancer-related mortality worldwide. The application of next-generation genomic technologies has offered a more comprehensive look at the mutational landscape across the different subtypes of non-small cell lung cancer (NSCLC). A number of recurrent mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Richer, Amanda L, Friel, Jacqueline M, Carson, Vashti M, Inge, Landon J, Whitsett, Timothy G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397718/
https://www.ncbi.nlm.nih.gov/pubmed/25897257
http://dx.doi.org/10.2147/PGPM.S52845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397718/
https://www.ncbi.nlm.nih.gov/pubmed/25897257
http://dx.doi.org/10.2147/PGPM.S52845

Ejemplares similares